Bank of Montreal’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bank of Montreal’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-125,900	Closed	-$14K	–	5047
2018 Q4	$14K	Buy	125,900 +100,000	+386%	+$65.6K	﹤0.01%	3782
2018 Q3	$44K	Hold	25,900	–	–	﹤0.01%	3449
2018 Q2	$45K	Buy	+25,900	New	+$44.8K	﹤0.01%	3459

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of Montreal's SGYP Position: Q1 2019 in Review

Bank of Montreal sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 130,224 shares — an estimated $14K sold.

Bank of Montreal first reported a position in SGYP in Q2 2013 and held it in 20 quarters. The position peaked at $335K in Q3 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Bank of Montreal reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Bank of Montreal sold 130,224 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $14K.
Bank of Montreal first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 20 quarters.
Bank of Montreal's Synergy Pharmaceuticals, Inc Common Stock position peaked at $335K in Q3 2017.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Bank of Montreal's 13F filing for Q1 2019, filed 26 Apr 2019.